Bloom Burton & Co. Announces the 2020 Bloom Burton Award Gala

Jan 28 17:01 2020 Print This Article

Bloom Burton & Co. Announces the 2020 Bloom Burton Award Gala

Annual Award Recognizes the Most Significant Contributor to Canada’s Innovative Healthcare Industry

Original press release here

January 28, 2020 07:30 AM Eastern Standard Time

TORONTO–(BUSINESS WIRE)–Bloom Burton & Co. (“Bloom Burton”) is thrilled to announce the 2020 Bloom Burton Award Gala, to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 24, 2020. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada’s innovative healthcare industry in the previous year. Nominees will be accepted from any of the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, services or healthcare IT sectors, and equal consideration will be given to contributions across any stage of development – from discovery to commercial end markets. The Bloom Burton Award recognizes the individual for their specific, significant contribution from the previous year.

Read More

About Article Author

Cross Border Biotech Blog

Bloom Burton & Co. is Canada's leading biotechnology and healthcare-specialized investment banking firm, which exists to accelerate returns in healthcare. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deeper level of diligence, which combined with a creative and entrepreneurial approach, leads to the right monetization events for companies and investors. Bloom Burton provides capital raising, M&A advisory, equity research, management consulting, direct investments through equity and debt funds, and company creation services.

Related Items

Market Update: Investors Optimistic as Global Economies Reopen

The quickest bear market in the history of the US S&P 500 turned into the best 50-day bull market rally in history in May. By market close on June 3, 2020, the S&P 500 Index was up 37.7% from its March 23, 2020 low. This bullish investor sentiment has been based on the continued decline in new coro ...

“E” vs “SG” in ethical investing: how sustainable is mollification-by-cherrypicking

In the great game of whack-a-mole that is capital raising in Canada’s oil patch, it must be frustrating, for those whose full-time job when there isn’t a global pandemic is whacking the moles of ESG criteria on which they feel their companies may be vulnerable to criticism and hence subject to ...

A deep retrofit of homes and buildings is the megaproject Canada needs

Ramping down carbon emissions from homes and buildings can help us rebuild Canada’s economy after the pandemic. ...

Rebuilding Canada’s economy includes energy resiliency in remote communities (blog)

This is the moment to create a roadmap for a society that is more resilient to these macro shocks – whether they are brought about by a pandemic or climate change. Canada’s response must support a more resilient, healthier economy that is competitive and shows economic strength in a decarbonize ...

Customer Success: Formulary Management

In response to customer requests, we’ve built some new tools for formulary management. You can preview these tools at: Recent Generic Drug Launches Upcoming 180-Day Patent Challenge Exclusivity Expirations Anticipate… The post Customer Success: Formulary Management appeared first on DrugPatentW ...

Ottawa postpones short-sighted drug-pricing regulations

Author: Bacchus Barua Planned changes would likely result in fewer new and innovative drugs available to Canadians. Read more about Ottawa postpones short-sighted drug-pricing regulations Tags:  pmprb pharmaceutical drugs pharmaceutical innovation prescription drug prices ...

Zymeworks ticks all the boxes for a biopharma investment, Paradigm says

Zymeworks (Zymeworks Stock Quote, Chart, News NYSE:ZYME) has what investors should be looking for in a biopharmaceutical company, according to Paradigm Capital analyst Corey Hammill, namely, a strong balance sheet and a healthy-looking pipeline. The analyst reviewed Zymeworks latest quarterly resul ...

Q4 2019 Share Price Performance

Q4 2019 Share Price Performance Healthcare Stocks Surge  In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 4Q-2019, and provides commentary on select stock movements and overall market trends.  Inclusion Criteria  Our ana ...

Filipino Healthcare Workers During COVID-19 and the Importance of Race-Based Analysis

Filipino Workers on the Frontlines During COVID19 Globally and in Canada Warlito Valdez. Amor Padilla Gatinao. Daisy Dorinilla. Debbie Accad. Leilani Medel. Christine Mandegarian.  These are just a few of the names of Filipino nurses, personal support workers, and caregivers in Canada, the United ...

Answers to FAQs about the recent market disruption

Global Market Strategist Brian Levitt provides perspective on the impact of the coronavirus and oil price wars.   1. Wasn’t the market due for a correction anyway? Market drawdowns typically don’t just happen for no apparent reason. They are the result of economic and/or policy uncertainty. Th ...